 Eric Simoes
Concepts (461)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 40 | 2018 | 117 | 5.740 |
Why?
| | Respiratory Syncytial Viruses | 18 | 2017 | 52 | 1.800 |
Why?
| | Respiratory Syncytial Virus, Human | 12 | 2018 | 68 | 1.300 |
Why?
| | Hospitalization | 19 | 2021 | 2080 | 0.960 |
Why?
| | Antibodies, Viral | 16 | 2025 | 598 | 0.930 |
Why?
| | Influenza, Human | 4 | 2024 | 603 | 0.870 |
Why?
| | Antibodies, Monoclonal | 9 | 2007 | 1359 | 0.850 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2002 | 131 | 0.770 |
Why?
| | Macaca radiata | 8 | 2003 | 15 | 0.750 |
Why?
| | Respiratory Tract Infections | 11 | 2017 | 372 | 0.740 |
Why?
| | Otoscopes | 1 | 2021 | 4 | 0.740 |
Why?
| | Infant | 59 | 2024 | 8994 | 0.720 |
Why?
| | Pneumococcal Vaccines | 2 | 2021 | 140 | 0.670 |
Why?
| | Seasons | 9 | 2021 | 502 | 0.660 |
Why?
| | Bronchiolitis, Viral | 4 | 2013 | 11 | 0.620 |
Why?
| | Antiviral Agents | 5 | 2007 | 708 | 0.620 |
Why?
| | Respiratory Syncytial Virus Vaccines | 4 | 2013 | 32 | 0.600 |
Why?
| | Suicide | 1 | 2023 | 584 | 0.530 |
Why?
| | Infant, Premature | 10 | 2007 | 540 | 0.510 |
Why?
| | Child, Preschool | 43 | 2024 | 10457 | 0.500 |
Why?
| | Poliovirus | 5 | 2001 | 76 | 0.490 |
Why?
| | India | 12 | 2024 | 167 | 0.480 |
Why?
| | Developing Countries | 11 | 2024 | 278 | 0.470 |
Why?
| | Infant, Newborn | 33 | 2025 | 5704 | 0.460 |
Why?
| | Measles | 2 | 2025 | 43 | 0.410 |
Why?
| | Infant, Premature, Diseases | 4 | 2002 | 95 | 0.410 |
Why?
| | Pneumonia | 10 | 2011 | 612 | 0.410 |
Why?
| | Palivizumab | 8 | 2007 | 13 | 0.410 |
Why?
| | Population Surveillance | 4 | 2024 | 428 | 0.390 |
Why?
| | Incidence | 10 | 2024 | 2634 | 0.390 |
Why?
| | Immunoglobulins | 3 | 2002 | 158 | 0.370 |
Why?
| | Viral Vaccines | 4 | 2005 | 93 | 0.370 |
Why?
| | Humans | 95 | 2025 | 128896 | 0.360 |
Why?
| | Prospective Studies | 17 | 2024 | 7060 | 0.350 |
Why?
| | Respiratory Sounds | 4 | 2013 | 121 | 0.340 |
Why?
| | Bronchiolitis | 6 | 1999 | 92 | 0.330 |
Why?
| | Virus Diseases | 3 | 2015 | 207 | 0.330 |
Why?
| | Child | 26 | 2024 | 20824 | 0.320 |
Why?
| | Pneumococcal Infections | 2 | 2008 | 110 | 0.310 |
Why?
| | Disease Outbreaks | 4 | 2021 | 333 | 0.300 |
Why?
| | Streptococcal Infections | 2 | 2024 | 145 | 0.300 |
Why?
| | Heart Defects, Congenital | 6 | 2005 | 752 | 0.300 |
Why?
| | Immunization, Passive | 4 | 2002 | 82 | 0.300 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2024 | 334 | 0.290 |
Why?
| | Carotid Artery Thrombosis | 1 | 2007 | 7 | 0.280 |
Why?
| | Spinal Cord | 2 | 2001 | 360 | 0.280 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2007 | 9 | 0.280 |
Why?
| | Antibodies, Monoclonal, Humanized | 9 | 2007 | 750 | 0.280 |
Why?
| | Mucormycosis | 1 | 2007 | 21 | 0.280 |
Why?
| | Philippines | 7 | 2021 | 50 | 0.280 |
Why?
| | Paranasal Sinus Diseases | 1 | 2007 | 14 | 0.280 |
Why?
| | Carotid Artery, Internal | 1 | 2007 | 41 | 0.280 |
Why?
| | Orbital Diseases | 1 | 2007 | 27 | 0.280 |
Why?
| | Poliovirus Vaccine, Inactivated | 4 | 1988 | 22 | 0.270 |
Why?
| | Female | 43 | 2025 | 68162 | 0.270 |
Why?
| | Antifungal Agents | 1 | 2007 | 132 | 0.260 |
Why?
| | Autopsy | 2 | 2023 | 89 | 0.260 |
Why?
| | Vaccines, Attenuated | 4 | 2001 | 122 | 0.260 |
Why?
| | Indonesia | 2 | 2024 | 20 | 0.250 |
Why?
| | Triazoles | 1 | 2007 | 153 | 0.250 |
Why?
| | Sex Work | 3 | 1993 | 19 | 0.250 |
Why?
| | Pneumonia, Viral | 5 | 2000 | 361 | 0.240 |
Why?
| | Male | 38 | 2025 | 63146 | 0.240 |
Why?
| | Child, Hospitalized | 1 | 2005 | 47 | 0.240 |
Why?
| | Immunoglobulin G | 3 | 2025 | 834 | 0.240 |
Why?
| | Bronchopulmonary Dysplasia | 6 | 1998 | 383 | 0.230 |
Why?
| | Asthma | 4 | 2002 | 2258 | 0.230 |
Why?
| | Community-Acquired Infections | 3 | 2015 | 153 | 0.230 |
Why?
| | Child Health Services | 2 | 2003 | 184 | 0.220 |
Why?
| | Metapneumovirus | 2 | 2013 | 13 | 0.210 |
Why?
| | Streptococcus agalactiae | 1 | 2024 | 91 | 0.210 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2024 | 145 | 0.210 |
Why?
| | Leukotriene Antagonists | 1 | 2003 | 43 | 0.210 |
Why?
| | Longitudinal Studies | 5 | 2023 | 2668 | 0.200 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2024 | 166 | 0.200 |
Why?
| | Measles Vaccine | 3 | 2025 | 19 | 0.200 |
Why?
| | Severity of Illness Index | 7 | 2008 | 2767 | 0.200 |
Why?
| | Poliomyelitis | 2 | 2001 | 27 | 0.200 |
Why?
| | Acetates | 1 | 2003 | 99 | 0.200 |
Why?
| | Bronchial Provocation Tests | 1 | 2002 | 50 | 0.200 |
Why?
| | Developed Countries | 1 | 2002 | 33 | 0.200 |
Why?
| | Quinolines | 1 | 2003 | 149 | 0.190 |
Why?
| | Cross Infection | 2 | 2013 | 203 | 0.190 |
Why?
| | Adult | 16 | 2025 | 35361 | 0.190 |
Why?
| | Risk Factors | 17 | 2017 | 9792 | 0.190 |
Why?
| | Altitude | 1 | 2006 | 451 | 0.190 |
Why?
| | Poliovirus Vaccine, Oral | 1 | 2001 | 19 | 0.190 |
Why?
| | Disease Models, Animal | 5 | 2003 | 3994 | 0.190 |
Why?
| | Cause of Death | 1 | 2023 | 392 | 0.190 |
Why?
| | Otoscopy | 1 | 2021 | 8 | 0.180 |
Why?
| | Length of Stay | 4 | 2005 | 1126 | 0.180 |
Why?
| | Young Adult | 5 | 2025 | 12286 | 0.180 |
Why?
| | Adolescent | 9 | 2025 | 20197 | 0.180 |
Why?
| | Peripheral Nerves | 1 | 2001 | 67 | 0.180 |
Why?
| | Mothers | 2 | 2005 | 723 | 0.180 |
Why?
| | Hospital Charges | 1 | 2000 | 41 | 0.170 |
Why?
| | Denmark | 3 | 2009 | 44 | 0.170 |
Why?
| | Diphtheria Toxoid | 3 | 1988 | 12 | 0.160 |
Why?
| | Pertussis Vaccine | 3 | 1988 | 21 | 0.160 |
Why?
| | Tetanus Toxoid | 3 | 1988 | 37 | 0.160 |
Why?
| | Environmental Exposure | 1 | 2003 | 479 | 0.160 |
Why?
| | Parvovirus B19, Human | 1 | 2018 | 3 | 0.150 |
Why?
| | Parvoviridae Infections | 1 | 2018 | 11 | 0.150 |
Why?
| | HN Protein | 1 | 1998 | 5 | 0.150 |
Why?
| | Colorado | 4 | 2021 | 4443 | 0.150 |
Why?
| | Anxiety | 1 | 2005 | 947 | 0.150 |
Why?
| | Respiratory Tract Diseases | 1 | 1999 | 151 | 0.150 |
Why?
| | Cost of Illness | 1 | 2000 | 290 | 0.150 |
Why?
| | Referral and Consultation | 1 | 2003 | 727 | 0.150 |
Why?
| | Virus Replication | 4 | 2003 | 448 | 0.150 |
Why?
| | Caregivers | 1 | 2005 | 821 | 0.140 |
Why?
| | Rickets | 1 | 1997 | 9 | 0.140 |
Why?
| | Viral Proteins | 2 | 1998 | 329 | 0.140 |
Why?
| | Air | 1 | 1997 | 36 | 0.140 |
Why?
| | Stress, Psychological | 1 | 2005 | 1051 | 0.140 |
Why?
| | Ventilator Weaning | 1 | 1997 | 35 | 0.140 |
Why?
| | RNA, Viral | 3 | 2001 | 622 | 0.140 |
Why?
| | Lung Diseases | 1 | 2003 | 755 | 0.140 |
Why?
| | Education, Nursing, Continuing | 1 | 1997 | 49 | 0.130 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 1987 | 226 | 0.120 |
Why?
| | Neutralization Tests | 3 | 2001 | 73 | 0.120 |
Why?
| | Pharyngeal Diseases | 1 | 1995 | 14 | 0.120 |
Why?
| | In Situ Hybridization | 3 | 2001 | 295 | 0.120 |
Why?
| | Postpartum Period | 1 | 2018 | 332 | 0.120 |
Why?
| | Jugular Veins | 1 | 1995 | 39 | 0.120 |
Why?
| | Mouth | 1 | 1995 | 81 | 0.120 |
Why?
| | Haemophilus Infections | 1 | 1995 | 40 | 0.120 |
Why?
| | Africa South of the Sahara | 2 | 2025 | 38 | 0.110 |
Why?
| | Abscess | 1 | 1995 | 73 | 0.110 |
Why?
| | Double-Blind Method | 8 | 2007 | 1858 | 0.110 |
Why?
| | Cerebral Aqueduct | 1 | 1994 | 4 | 0.110 |
Why?
| | Infectious Mononucleosis | 1 | 1994 | 9 | 0.110 |
Why?
| | Respirovirus Infections | 2 | 1993 | 23 | 0.110 |
Why?
| | Otitis Media | 1 | 1996 | 163 | 0.110 |
Why?
| | Gestational Age | 3 | 2005 | 857 | 0.110 |
Why?
| | Nucleoproteins | 1 | 2013 | 28 | 0.110 |
Why?
| | Pregnancy | 5 | 2025 | 6247 | 0.110 |
Why?
| | HIV Infections | 3 | 2018 | 2696 | 0.110 |
Why?
| | Human bocavirus | 1 | 2013 | 1 | 0.110 |
Why?
| | Models, Statistical | 1 | 2017 | 626 | 0.110 |
Why?
| | Triplets | 1 | 1993 | 2 | 0.110 |
Why?
| | HIV Antibodies | 1 | 1993 | 58 | 0.110 |
Why?
| | South Africa | 3 | 2024 | 191 | 0.110 |
Why?
| | Oropharynx | 1 | 2013 | 42 | 0.100 |
Why?
| | Primary Health Care | 1 | 2003 | 1661 | 0.100 |
Why?
| | Hydrocephalus | 1 | 1994 | 104 | 0.100 |
Why?
| | Disease Management | 1 | 1997 | 594 | 0.100 |
Why?
| | Pediatric Nursing | 1 | 1992 | 41 | 0.100 |
Why?
| | Cohort Studies | 4 | 2018 | 5394 | 0.100 |
Why?
| | Community Health Workers | 1 | 1992 | 50 | 0.100 |
Why?
| | Vaccines, Inactivated | 2 | 2003 | 69 | 0.100 |
Why?
| | Encephalitis | 1 | 1994 | 130 | 0.100 |
Why?
| | Case-Control Studies | 5 | 2018 | 3334 | 0.100 |
Why?
| | Diseases in Twins | 1 | 1993 | 174 | 0.100 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1991 | 30 | 0.090 |
Why?
| | Europe | 2 | 2003 | 366 | 0.090 |
Why?
| | Thrombosis | 1 | 1995 | 331 | 0.090 |
Why?
| | Pneumonia, Bacterial | 2 | 2009 | 112 | 0.090 |
Why?
| | Respiratory Function Tests | 3 | 2002 | 596 | 0.090 |
Why?
| | Aged | 5 | 2024 | 22035 | 0.090 |
Why?
| | Ulnar Nerve | 2 | 2001 | 16 | 0.090 |
Why?
| | Age Distribution | 4 | 2007 | 376 | 0.090 |
Why?
| | Breast Feeding | 2 | 2003 | 423 | 0.090 |
Why?
| | Genes, Viral | 1 | 1991 | 94 | 0.090 |
Why?
| | Retrospective Studies | 6 | 2023 | 14546 | 0.090 |
Why?
| | Time Factors | 7 | 2018 | 6568 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1192 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 778 | 0.090 |
Why?
| | Middle Aged | 5 | 2024 | 30977 | 0.080 |
Why?
| | Clinical Competence | 1 | 1997 | 1020 | 0.080 |
Why?
| | Measles virus | 2 | 2025 | 13 | 0.080 |
Why?
| | Logistic Models | 4 | 2009 | 1963 | 0.080 |
Why?
| | Lung | 2 | 2001 | 3925 | 0.080 |
Why?
| | Algorithms | 3 | 2009 | 1626 | 0.080 |
Why?
| | Sensitivity and Specificity | 5 | 2007 | 1840 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 1991 | 409 | 0.080 |
Why?
| | Animals | 10 | 2004 | 34628 | 0.080 |
Why?
| | Single-Blind Method | 3 | 1998 | 273 | 0.070 |
Why?
| | Global Health | 2 | 2017 | 317 | 0.070 |
Why?
| | Mozambique | 2 | 2024 | 6 | 0.070 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 159 | 0.070 |
Why?
| | Respiration | 3 | 1997 | 191 | 0.070 |
Why?
| | Mucor | 1 | 2007 | 7 | 0.070 |
Why?
| | HIV-1 | 1 | 1993 | 840 | 0.070 |
Why?
| | Ethiopia | 2 | 1997 | 35 | 0.070 |
Why?
| | United States | 6 | 2007 | 13975 | 0.070 |
Why?
| | Prevalence | 2 | 2024 | 2540 | 0.070 |
Why?
| | Debridement | 1 | 2007 | 87 | 0.070 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2006 | 5 | 0.070 |
Why?
| | Weather | 1 | 2007 | 35 | 0.070 |
Why?
| | Meningitis, Bacterial | 1 | 2007 | 52 | 0.070 |
Why?
| | Reference Values | 2 | 2007 | 791 | 0.070 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2007 | 44 | 0.070 |
Why?
| | Rectum | 2 | 2024 | 166 | 0.070 |
Why?
| | Probability | 1 | 2007 | 313 | 0.070 |
Why?
| | Cell Line | 3 | 2004 | 2759 | 0.070 |
Why?
| | Deltaretrovirus | 1 | 1985 | 12 | 0.060 |
Why?
| | Predictive Value of Tests | 5 | 2009 | 1967 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2007 | 238 | 0.060 |
Why?
| | Convalescence | 1 | 2005 | 18 | 0.060 |
Why?
| | Asia, Southeastern | 1 | 2025 | 11 | 0.060 |
Why?
| | DNA, Bacterial | 1 | 2007 | 324 | 0.060 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2025 | 18 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 760 | 0.060 |
Why?
| | Biomedical Research | 1 | 2011 | 654 | 0.060 |
Why?
| | Athetosis | 1 | 2005 | 7 | 0.060 |
Why?
| | Chorea | 1 | 2005 | 11 | 0.060 |
Why?
| | Cyanosis | 2 | 2009 | 16 | 0.060 |
Why?
| | Pediatrics | 3 | 2001 | 1060 | 0.060 |
Why?
| | Antibodies, Bacterial | 2 | 2000 | 137 | 0.060 |
Why?
| | Bhutan | 1 | 2024 | 3 | 0.060 |
Why?
| | Seroepidemiologic Studies | 1 | 2025 | 155 | 0.060 |
Why?
| | Blood Donors | 1 | 1985 | 94 | 0.060 |
Why?
| | Asia | 1 | 2024 | 58 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 772 | 0.060 |
Why?
| | Paramyxoviridae | 1 | 2004 | 2 | 0.060 |
Why?
| | Paramyxoviridae Infections | 1 | 2004 | 11 | 0.060 |
Why?
| | Africa | 1 | 2024 | 96 | 0.060 |
Why?
| | Maxillary Sinus | 1 | 2004 | 11 | 0.060 |
Why?
| | Maxillary Sinusitis | 1 | 2004 | 7 | 0.060 |
Why?
| | Sinusitis | 2 | 1999 | 204 | 0.060 |
Why?
| | Family Health | 1 | 2005 | 199 | 0.060 |
Why?
| | Orthomyxoviridae | 1 | 2004 | 39 | 0.060 |
Why?
| | Hypothermia, Induced | 1 | 2005 | 74 | 0.060 |
Why?
| | Orthomyxoviridae Infections | 1 | 2004 | 65 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 336 | 0.050 |
Why?
| | Equipment and Supplies | 1 | 2003 | 40 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1504 | 0.050 |
Why?
| | U937 Cells | 1 | 2003 | 23 | 0.050 |
Why?
| | Blood Transfusion | 1 | 1985 | 294 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2004 | 107 | 0.050 |
Why?
| | Acute Disease | 3 | 2013 | 978 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2005 | 338 | 0.050 |
Why?
| | Spain | 1 | 2003 | 36 | 0.050 |
Why?
| | Steroids | 2 | 2001 | 148 | 0.050 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 3 | 1988 | 26 | 0.050 |
Why?
| | Cyclopropanes | 1 | 2003 | 88 | 0.050 |
Why?
| | Cell Count | 2 | 2004 | 316 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1968 | 0.050 |
Why?
| | Demography | 1 | 2003 | 280 | 0.050 |
Why?
| | Odds Ratio | 2 | 1997 | 1019 | 0.050 |
Why?
| | Malnutrition | 1 | 2003 | 78 | 0.050 |
Why?
| | Climate | 1 | 2003 | 87 | 0.050 |
Why?
| | Vagina | 1 | 2024 | 173 | 0.050 |
Why?
| | Geography | 1 | 2003 | 185 | 0.050 |
Why?
| | Sulfides | 1 | 2003 | 94 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 2 | 1997 | 226 | 0.050 |
Why?
| | Japan | 1 | 2002 | 100 | 0.050 |
Why?
| | Rhinitis | 1 | 2004 | 152 | 0.050 |
Why?
| | Phylogeny | 2 | 2018 | 843 | 0.050 |
Why?
| | Morbidity | 1 | 2003 | 301 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2002 | 137 | 0.050 |
Why?
| | Drug Combinations | 3 | 1988 | 327 | 0.050 |
Why?
| | Treatment Outcome | 7 | 2007 | 10239 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2002 | 129 | 0.050 |
Why?
| | Vaccines, Subunit | 1 | 2001 | 47 | 0.050 |
Why?
| | Body Weight | 1 | 1986 | 931 | 0.050 |
Why?
| | Formaldehyde | 1 | 2001 | 57 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2007 | 4917 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2001 | 675 | 0.050 |
Why?
| | Hospitals, District | 1 | 2001 | 6 | 0.050 |
Why?
| | Virus Shedding | 1 | 2001 | 44 | 0.050 |
Why?
| | Canada | 1 | 2002 | 355 | 0.040 |
Why?
| | Models, Immunological | 1 | 2001 | 94 | 0.040 |
Why?
| | Mortality | 1 | 2003 | 310 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 492 | 0.040 |
Why?
| | Health Services Research | 1 | 2003 | 392 | 0.040 |
Why?
| | Macaca | 1 | 1980 | 53 | 0.040 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1980 | 42 | 0.040 |
Why?
| | Serum Albumin | 1 | 2001 | 145 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2001 | 112 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 822 | 0.040 |
Why?
| | Viremia | 1 | 2001 | 133 | 0.040 |
Why?
| | Oxygen | 1 | 2005 | 912 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 2 | 2001 | 468 | 0.040 |
Why?
| | Influenza B virus | 2 | 2004 | 37 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 812 | 0.040 |
Why?
| | Neuroglia | 1 | 2001 | 165 | 0.040 |
Why?
| | Nasopharynx | 2 | 1998 | 67 | 0.040 |
Why?
| | Wrist | 1 | 1980 | 52 | 0.040 |
Why?
| | Tobacco Smoke Pollution | 1 | 2003 | 232 | 0.040 |
Why?
| | Intensive Care Units, Pediatric | 2 | 1998 | 189 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5032 | 0.040 |
Why?
| | BCG Vaccine | 1 | 1999 | 24 | 0.040 |
Why?
| | Sex Factors | 2 | 2003 | 1947 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2000 | 124 | 0.040 |
Why?
| | Influenza A virus | 2 | 2004 | 104 | 0.040 |
Why?
| | Cardiac Surgical Procedures | 1 | 2005 | 501 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 1999 | 200 | 0.040 |
Why?
| | Age Factors | 4 | 2006 | 3133 | 0.040 |
Why?
| | Fever | 2 | 2018 | 301 | 0.040 |
Why?
| | Hand | 1 | 1980 | 150 | 0.040 |
Why?
| | Patient Discharge | 1 | 2005 | 858 | 0.040 |
Why?
| | Hospital Mortality | 2 | 2017 | 853 | 0.040 |
Why?
| | Antigens, Viral | 1 | 1999 | 181 | 0.040 |
Why?
| | Parvovirus | 1 | 2018 | 13 | 0.040 |
Why?
| | Vaccination | 2 | 2001 | 1350 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2003 | 730 | 0.040 |
Why?
| | Research | 1 | 2001 | 413 | 0.040 |
Why?
| | Risk Assessment | 1 | 2007 | 3286 | 0.040 |
Why?
| | Vaccines, Combined | 2 | 1988 | 48 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 392 | 0.040 |
Why?
| | Nutrition Disorders | 1 | 1997 | 23 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 1998 | 85 | 0.030 |
Why?
| | Child Nutrition Disorders | 1 | 1997 | 17 | 0.030 |
Why?
| | World Health Organization | 2 | 2008 | 106 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2009 | 1523 | 0.030 |
Why?
| | Bacterial Infections | 2 | 2007 | 236 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1999 | 813 | 0.030 |
Why?
| | Neutrophils | 1 | 2002 | 1203 | 0.030 |
Why?
| | Nursing Assessment | 1 | 1997 | 54 | 0.030 |
Why?
| | Dehydration | 1 | 1997 | 48 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2000 | 615 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 642 | 0.030 |
Why?
| | Birth Weight | 2 | 1993 | 493 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 1999 | 403 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 1997 | 105 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2003 | 894 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2001 | 610 | 0.030 |
Why?
| | Macrophages, Alveolar | 1 | 1999 | 389 | 0.030 |
Why?
| | DNA, Viral | 1 | 2018 | 380 | 0.030 |
Why?
| | Bangladesh | 1 | 2015 | 42 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1542 | 0.030 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1997 | 146 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3348 | 0.030 |
Why?
| | Lung Abscess | 1 | 1995 | 7 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 50 | 0.030 |
Why?
| | Blood | 1 | 2015 | 99 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2015 | 53 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 94 | 0.030 |
Why?
| | Nutritional Status | 1 | 1997 | 325 | 0.030 |
Why?
| | Prognosis | 1 | 2003 | 3787 | 0.030 |
Why?
| | Fruit | 1 | 1995 | 131 | 0.030 |
Why?
| | Eating | 2 | 1999 | 366 | 0.030 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 1994 | 37 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 1997 | 676 | 0.030 |
Why?
| | Vegetables | 1 | 1995 | 146 | 0.030 |
Why?
| | Ribavirin | 1 | 1994 | 92 | 0.030 |
Why?
| | Opportunistic Infections | 1 | 1993 | 46 | 0.030 |
Why?
| | Counseling | 1 | 1997 | 382 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 1994 | 230 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 1994 | 153 | 0.030 |
Why?
| | Crowding | 1 | 1993 | 36 | 0.030 |
Why?
| | Neurons | 1 | 2001 | 1425 | 0.030 |
Why?
| | Influenza Vaccines | 1 | 1998 | 544 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 1997 | 594 | 0.030 |
Why?
| | Hospitals, University | 1 | 1993 | 177 | 0.030 |
Why?
| | Radiography | 3 | 2008 | 863 | 0.020 |
Why?
| | Methods | 1 | 1991 | 63 | 0.020 |
Why?
| | Sexual Partners | 1 | 1993 | 179 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1999 | 2700 | 0.020 |
Why?
| | Rural Population | 1 | 2015 | 504 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1991 | 28 | 0.020 |
Why?
| | Psychomotor Agitation | 1 | 1991 | 65 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2013 | 198 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 957 | 0.020 |
Why?
| | Inflammation | 1 | 2001 | 2694 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1991 | 356 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1991 | 536 | 0.020 |
Why?
| | Rural Health | 1 | 2009 | 70 | 0.020 |
Why?
| | Sexual Behavior | 1 | 1993 | 453 | 0.020 |
Why?
| | Typhoid-Paratyphoid Vaccines | 1 | 1989 | 4 | 0.020 |
Why?
| | HeLa Cells | 1 | 1991 | 602 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 1993 | 518 | 0.020 |
Why?
| | Salmonella typhi | 1 | 1989 | 13 | 0.020 |
Why?
| | Typhoid Fever | 1 | 1989 | 10 | 0.020 |
Why?
| | Transfection | 1 | 1991 | 904 | 0.020 |
Why?
| | Genetic Variation | 1 | 2013 | 935 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 1991 | 705 | 0.020 |
Why?
| | Meteorological Concepts | 1 | 2007 | 6 | 0.020 |
Why?
| | Kinetics | 1 | 1991 | 1619 | 0.020 |
Why?
| | Buchnera | 1 | 2007 | 1 | 0.020 |
Why?
| | Half-Life | 2 | 1999 | 148 | 0.020 |
Why?
| | Diet | 1 | 1995 | 1205 | 0.020 |
Why?
| | Base Sequence | 1 | 1991 | 2157 | 0.020 |
Why?
| | Humidity | 1 | 2007 | 50 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2007 | 69 | 0.020 |
Why?
| | Hypersensitivity, Immediate | 1 | 2006 | 48 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1991 | 2842 | 0.020 |
Why?
| | Weaning | 1 | 1986 | 49 | 0.020 |
Why?
| | Anti-Bacterial Agents | 3 | 2007 | 1701 | 0.020 |
Why?
| | Sleep | 1 | 1991 | 657 | 0.020 |
Why?
| | Models, Molecular | 1 | 1991 | 1477 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2007 | 136 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1985 | 175 | 0.020 |
Why?
| | Chronic Disease | 2 | 2004 | 1715 | 0.020 |
Why?
| | Antibody Formation | 1 | 1987 | 284 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 1986 | 134 | 0.020 |
Why?
| | Nigeria | 1 | 2005 | 14 | 0.020 |
Why?
| | Acid-Base Equilibrium | 1 | 2005 | 27 | 0.010 |
Why?
| | Parainfluenza Virus 2, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 1, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2004 | 5 | 0.010 |
Why?
| | Nasal Lavage Fluid | 1 | 2004 | 14 | 0.010 |
Why?
| | Virus Cultivation | 1 | 2004 | 28 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1283 | 0.010 |
Why?
| | Adenoviruses, Human | 1 | 2004 | 26 | 0.010 |
Why?
| | Exocrine Glands | 1 | 2004 | 5 | 0.010 |
Why?
| | Basement Membrane | 1 | 2004 | 33 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2007 | 385 | 0.010 |
Why?
| | Risk | 1 | 1987 | 866 | 0.010 |
Why?
| | Immunization Schedule | 1 | 1985 | 197 | 0.010 |
Why?
| | Body Temperature | 1 | 2005 | 215 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 634 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1045 | 0.010 |
Why?
| | Plasma Cells | 1 | 2004 | 65 | 0.010 |
Why?
| | Immunization | 1 | 1986 | 416 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 542 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2005 | 193 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 1884 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1999 | 3601 | 0.010 |
Why?
| | Escherichia coli | 1 | 2007 | 782 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2005 | 261 | 0.010 |
Why?
| | Esophagus | 1 | 2005 | 253 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1366 | 0.010 |
Why?
| | Phenotype | 1 | 1991 | 3059 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 369 | 0.010 |
Why?
| | Eosinophils | 1 | 2004 | 324 | 0.010 |
Why?
| | Metacarpophalangeal Joint | 1 | 1980 | 12 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1093 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 1 | 2000 | 67 | 0.010 |
Why?
| | Medical Records | 1 | 2000 | 170 | 0.010 |
Why?
| | Nasal Decongestants | 1 | 1999 | 8 | 0.010 |
Why?
| | Placebos | 1 | 1999 | 203 | 0.010 |
Why?
| | Glutamate Decarboxylase | 1 | 1999 | 165 | 0.010 |
Why?
| | Insulin Antibodies | 1 | 1999 | 104 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 1999 | 33 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1999 | 127 | 0.010 |
Why?
| | C-Peptide | 1 | 1999 | 163 | 0.010 |
Why?
| | Triage | 1 | 2001 | 211 | 0.010 |
Why?
| | Bacteremia | 1 | 2000 | 190 | 0.010 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 162 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1999 | 1213 | 0.010 |
Why?
| | Recurrence | 1 | 1999 | 1013 | 0.010 |
Why?
| | Physical Examination | 1 | 1997 | 237 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 1995 | 20 | 0.010 |
Why?
| | European Continental Ancestry Group | 1 | 1995 | 1 | 0.010 |
Why?
| | African Americans | 1 | 1995 | 3 | 0.010 |
Why?
| | Patient Selection | 1 | 1999 | 671 | 0.010 |
Why?
| | Diet Surveys | 1 | 1995 | 92 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 1999 | 729 | 0.010 |
Why?
| | Random Allocation | 1 | 1995 | 351 | 0.010 |
Why?
| | Telephone | 1 | 1995 | 167 | 0.010 |
Why?
| | Marriage | 1 | 1995 | 111 | 0.010 |
Why?
| | Islets of Langerhans | 1 | 1999 | 792 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1997 | 1435 | 0.010 |
Why?
| | Autoantibodies | 1 | 1999 | 1460 | 0.010 |
Why?
| | Acetaminophen | 1 | 1994 | 255 | 0.010 |
Why?
| | Tropical Climate | 1 | 1991 | 18 | 0.010 |
Why?
| | Pleura | 1 | 1991 | 22 | 0.010 |
Why?
| | Pharynx | 1 | 1991 | 56 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1992 | 255 | 0.010 |
Why?
| | Blood Glucose | 1 | 1999 | 2086 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2001 | 1977 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 3042 | 0.010 |
Why?
| | Insulin | 1 | 1999 | 2311 | 0.000 |
Why?
| | Monitoring, Physiologic | 1 | 1991 | 265 | 0.000 |
Why?
| | Injections, Subcutaneous | 1 | 1989 | 145 | 0.000 |
Why?
| | Antigens, Bacterial | 1 | 1989 | 120 | 0.000 |
Why?
| | Thorax | 1 | 1988 | 41 | 0.000 |
Why?
| | Sepsis | 1 | 1991 | 561 | 0.000 |
Why?
|
|
Simoes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|